Partell Specialty Pharmacy Recalls CoEnzymeQ10 Vials Due to Sterility Concerns
Partell Specialty Pharmacy is recalling CoEnzymeQ10 25mg/mL vials because they were sterilized using a non-approved method.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric for significant injury or property damage reports or high-risk scenarios.
Plain-English summary
Partell Specialty Pharmacy is recalling CoEnzymeQ10 25mg/mL, 5mL amber vials due to a lack of assurance of sterility. The recall is being conducted because the firm used a non-approved method of sterilization for these drug products.
The affected products are prescription-only and were distributed only in Nevada. The recall includes three vials with specific lot numbers and expiration dates: Lot 20171227@14 (BUD 03/27/2018), Lot 20180205@37 (BUD 05/06/2018), and Lot 20180214@30 (BUD 05/15/2018).
Consumers who have these specific vials should stop using them and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- CoEnzymeQ10 25mg/mL, 5mL amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800.
- Manufacturer
- Partell Specialty Pharmacy
- Category
- Drug — Pharmacy Compounded
- Affected units
- 3
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot#: 20171227@14
- BUD 03/27/2018
- 20180205@37
- BUD 05/06/2018
- 20180214@30
- BUD 05/15/2018.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 49 recalled by Partell Specialty Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 49 products in this recall →Related recalls
Same manufacturer · Partell Specialty Pharmacy
See all →- SeverePartell Specialty Pharmacy Recalls Glutathione Vials Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Nandrolone Decanoate Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- HighPartell Specialty Pharmacy Recalls Estradiol Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Ascorbic Acid Vials Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereDowning Labs Recalls Co-Enzyme Q-10 Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereAuro Pharmacies Recalls CoEnzyme-Q10 Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-09-05
- HighWell Care Compounding Pharmacy Recalls Estradiol Valerate Due to Sterility Concerns
FDA (Drugs) · 2016-06-15
- SevereWell Care Compounding Pharmacy Recalls QUAD-MIX #1 Due to Sterility Concerns
FDA (Drugs) · 2016-06-15
- SevereAxia Pharmaceutical Recalls Coenzyme Q10 Injection Due to Sterility Concerns
FDA (Drugs) · 2020-03-11
- SevereWell Care Compounding Pharmacy Recalls QUAD-MIX #3 Due to Sterility Concerns
FDA (Drugs) · 2016-06-15